napsgear semaglutide Demand Rising for 'Bootlegged' Weight-Loss Drug Semaglutide: Half of Users Stop

By helping you feel full faster, Tirzepatide may support reduced food intake and weight loss

Research has consistently shown that GLP-1 receptor agonists, such as Tirzepatide, are safe and effective for long-term treatment of type 2 diabetes and obesity, offering exciting potential for combating the global obesity epidemic

Low-income adults on Medi-Cal, who cannot afford private coverage, are exactly the population for whom alternative weight loss pathways are least accessible

Patients not on treatment or on other antihyperglycemic agents entered a run-in treatment period of up to 12 weeks duration with metformin monotherapy (dose of 1500 mg per day) which included washout of medications other than metformin, if applicable